Status:
UNKNOWN
In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer
Lead Sponsor:
ARNA Genomics US Inc.
Collaborating Sponsors:
BIOMARKER-RU
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
35-65 years
Brief Summary
The Study Objective is to evaluate the diagnostic efficacy of the liquid biopsy system versus the gold standard mammography (or MRI, or Ultrasound) diagnosis in patients with suspected breast cancer.
Detailed Description
Women of the required age group, in case of suspicion of breast cancer, are sent to clarify the diagnosis for mammography or ultrasound of the mammary glands, or MRI. Based on the results of these stu...
Eligibility Criteria
Inclusion
- Availability of signed and dated informed consent.
- Women from 35 to 65 years old, who are generally healthy, with suspected breast cancer. Or without suspicion of (control group)
- Presence of a documented referral diagnosis of "breast cancer"
- Presence of a documented biopsy referral
- Presence of mammography, ultrasound or MRI of the mammary glands no later than three months.
Exclusion
- Pregnancy.
- Any other cancers diagnosed now or previously, with the exception of breast cancer.
- Therapy with cytostatics during the last three months.
- Chemotherapy within the past three months.
- Therapy with hormonal drugs, including all forms of contraceptive drugs.
- Therapy with other prohibited groups of drugs.
- Systolic blood pressure \> 180 mm Hg. and / or diastolic blood pressure \> 120 mm Hg. with repeated measurements.
- Simultaneous participation in another clinical study.
- Relative affiliation to the clinic, for example, the patient is a close relative of the researcher or a dependent person (for example, a clinic employee or student or a sponsor employee).
- A clinically significant condition or laboratory result that, in the opinion of the investigator, threatens the safety of the test subject, may interfere with assessments, or prevent the completion of the study.
- Failure to cooperate to participate in planned procedures, including the following examples: lack of understanding of language, mental illness, inability to visit the clinic.
- Diseases or conditions that may affect the conduct of the study or the interpretation of the results.
- History of organ transplantation.
- Blood transfusions within the last 6 months.
Key Trial Info
Start Date :
May 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04890340
Start Date
May 21 2021
End Date
December 31 2021
Last Update
May 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.